UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Barriers, facilitators, and solutions to familial hypercholesterolemia treatment

PloS one, 2020-12, Vol.15 (12), p.e0244193-e0244193

2020

Link zum Volltext

Verfügbarkeit prüfen

Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis

Implementation science : IS, 2021-04, Vol.16 (1), p.40-40, Article 40

2021

Link zum Volltext

Verfügbarkeit prüfen

Observational study of population genomic screening for variants associated with endocrine tumor syndromes in a large, healthcare-based cohort

BMC medicine, 2022-06, Vol.20 (1), p.205-205, Article 205

2022

Link zum Volltext

Verfügbarkeit prüfen

Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia

Journal of the American Heart Association, 2021-09, Vol.10 (17), p.e020890-e020890

2021

Link zum Volltext

Verfügbarkeit prüfen

SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia

Proceedings of the National Academy of Sciences - PNAS, 2015-10, Vol.112 (40), p.12528-12533

2015

Link zum Volltext

Verfügbarkeit prüfen

Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia

BMC health services research, 2023-04, Vol.23 (1), p.340-340, Article 340

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenomic (PGx) Counseling: Exploring Participant Questions about PGx Test Results

Journal of personalized medicine, 2020-04, Vol.10 (2), p.29

2020

Link zum Volltext

Verfügbarkeit prüfen

Inherited cobalamin malabsorption. Mutations in three genes reveal functional and ethnic patterns

Orphanet journal of rare diseases, 2012-08, Vol.7 (1), p.56-56

2012

Link zum Volltext

Verfügbarkeit prüfen

A RE-AIM Framework Analysis of DNA-Based Population Screening: Using Implementation Science to Translate Research Into Practice in a Healthcare System

Frontiers in genetics, 2022-05, Vol.13, p.883073-883073

2022

Link zum Volltext

Verfügbarkeit prüfen

Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnoses After Electronic Health Record and Genomic Data Screening

Journal of the American Heart Association, 2023-07, Vol.12 (13), p.e8572-e030073

2023

Link zum Volltext

Verfügbarkeit prüfen

Barriers and Facilitators to Genetic Testing for Familial Hypercholesterolemia in the United States: A Review

Journal of personalized medicine, 2019-07, Vol.9 (3), p.32

2019

Link zum Volltext

Verfügbarkeit prüfen

Hidden Burden of Electronic Health Record-Identified Familial Hypercholesterolemia: Clinical Outcomes and Cost of Medical Care

Journal of the American Heart Association, 2019-07, Vol.8 (13), p.e011822-e011822

2019

Link zum Volltext

Verfügbarkeit prüfen

Investigating Psychological Impact after Receiving Genetic Risk Results-A Survey of Participants in a Population Genomic Screening Program

Journal of personalized medicine, 2022-11, Vol.12 (12), p.1943

2022

Link zum Volltext

Verfügbarkeit prüfen

An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome

Circulation (New York, N.Y.), 2020-02, Vol.141 (6), p.418-428

2020

Link zum Volltext

Verfügbarkeit prüfen

Reappraisal of Reported Genes for Sudden Arrhythmic Death: Evidence-Based Evaluation of Gene Validity for Brugada Syndrome

Circulation (New York, N.Y.), 2018-09, Vol.138 (12), p.1195-1205

2018

Link zum Volltext

Verfügbarkeit prüfen

Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study

PEC innovation, 2023-12, Vol.2, p.100134-100134, Article 100134

2023

Link zum Volltext

Verfügbarkeit prüfen

Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps

Nature medicine, 2021-11, Vol.27 (11), p.1876-1884

2021

Link zum Volltext

Verfügbarkeit prüfen

Association between triglycerides, known risk SNVs and conserved rare variation in SLC25A40 in a multi-ancestry cohort

BMC medical genomics, 2021-01, Vol.14 (1), p.11-11, Article 11

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a multidisciplinary lipid clinic to improve the care of individuals with severe lipid conditions: a RE-AIM framework analysis

Implementation science communications, 2021-03, Vol.2 (1), p.32-32, Article 32

2021

Link zum Volltext

Verfügbarkeit prüfen

Patient experiences align with the familial hypercholesterolemia global call to action

American journal of preventive cardiology, 2022-06, Vol.10, p.100344-100344, Article 100344

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel

Journal of the American College of Cardiology, 2018-08, Vol.72 (6), p.662-680

2018

Link zum Volltext

Verfügbarkeit prüfen

Heterozygous Familial Hypercholesterolemia

Circulation (New York, N.Y.), 2016-04, Vol.133 (14), p.e587-e589

2016

Link zum Volltext

Verfügbarkeit prüfen

How Online Family History Tool Design and Message Content Impact User Perceptions: An Examination of Family HealthLink

Public health genomics, 2018-01, Vol.21 (1/2), p.53-66

2018

Link zum Volltext

Verfügbarkeit prüfen

Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study

Journal of personalized medicine, 2021-06, Vol.11 (6), p.587

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(136)

Publikationsform

Sprache

Englisch
(146)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Barriers, facilitators, and solutions to familial hypercholesterolemia treatment

Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis

Observational study of population genomic screening for variants associated with endocrine tumor syndromes in a large, healthcare-based cohort

Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia

SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia

Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia

Pharmacogenomic (PGx) Counseling: Exploring Participant Questions about PGx Test Results

Inherited cobalamin malabsorption. Mutations in three genes reveal functional and ethnic patterns

A RE-AIM Framework Analysis of DNA-Based Population Screening: Using Implementation Science to Translate Research Into Practice in a Healthcare System

Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnoses After Electronic Health Record and Genomic Data Screening

Barriers and Facilitators to Genetic Testing for Familial Hypercholesterolemia in the United States: A Review

Hidden Burden of Electronic Health Record-Identified Familial Hypercholesterolemia: Clinical Outcomes and Cost of Medical Care

Investigating Psychological Impact after Receiving Genetic Risk Results-A Survey of Participants in a Population Genomic Screening Program

Pediatric reporting of genomic results study (PROGRESS): a mixed-methods, longitudinal, observational cohort study protocol to explore disclosure of actionable adult- and pediatric-onset genomic variants to minors and their parents

An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome

Reappraisal of Reported Genes for Sudden Arrhythmic Death: Evidence-Based Evaluation of Gene Validity for Brugada Syndrome

Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study

Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps

Association between triglycerides, known risk SNVs and conserved rare variation in SLC25A40 in a multi-ancestry cohort

Evaluation of a multidisciplinary lipid clinic to improve the care of individuals with severe lipid conditions: a RE-AIM framework analysis

Patient experiences align with the familial hypercholesterolemia global call to action

Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel

Heterozygous Familial Hypercholesterolemia

How Online Family History Tool Design and Message Content Impact User Perceptions: An Examination of Family HealthLink

Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study

Suchergebnisse filtern